Stockreport

BioCardia shares climb as it gets FDA clearance for its Morph DNA product family Aug. 29, 2024 9:07 AM ET By: Akanksha Khushi , SA News Editor [Seeking Alpha]

BioCardia, Inc.  (BCDA) 
PDF cleared the company to market its Morph DNA Steerable Introducer product family. The clearance covers sixteen products in lengths of 30, 45, 71, and 90 centimeters [Read more]